USPTO serial 79251614
WERFEN
Reviewed by CopyMark Law Group
Reg. 5934651Status 709
- Filing date
- Status date
- Registration date
- Dec 17, 2019
- Examiner
- PATEL, SAMIR RAMESH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with WERFEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Deborah J. Peckham
Deborah J. Peckham Barclay Damon LLP160 Federal Street, Suite 1001Boston, MA 02110United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic reagents for medical or veterinary use; immunoassay reagents for medical or veterinary use; medical reagents for clinical use; reagents for clinical analysis for medical or veterinary use; reagents for microbiological analysis for medical or veterinary use; reagents for use in analyzers for medical or veterinary purposes; reagents for in-vitro use in laboratories for medical or veterinary purposes; chemical reagents for testing for medical or veterinary use | SECTION 71 - CANCELLED | — |
| 010 | Medical apparatus and instruments for analysis in laboratories and clinical diagnosis of human disease in the nature of automated coagulation analyzers, namely, electronic instruments for measuring the characteristics and components of blood clots; Medical apparatus and instruments for analysis in laboratories and clinical diagnosis of human diseases in the nature of automated analyzers of body fluids, namely, automated instruments for measuring blood gases, hematocrit, hemoglobin, electrolytes and other body fluid analyses; Medical apparatus and instruments for analysis in laboratories and clinical diagnosis of human diseases in the nature of disposable cartridges containing reagents for diagnostic tests of body fluids in an automated body fluid analyzer; Medical apparatus and instruments for analysis in laboratories and clinical diagnosis of human diseases in the nature of automated clinical analyzers, namely, electronic instruments for measuring partial pressures of oxygen and carbon dioxide and ionic activity in the blood | SECTION 71 - CANCELLED | — |
| 035 | Retail store services featuring in-vitro diagnosis and analysis products, apparatus and instruments, diagnostic kits comprising receivers for samples and reagents for testing selected bacteria, equipment for biomolecular tagging consisting of reagents for use in scientific research, mixtures of chemical reagents in kit form, other than those for medical or veterinary use, mixtures of chemical reagents, not for medical or veterinary use, testing reagents for scientific use, monoclonal antibody reagents for medical use, diagnostic reagents, other than for use in medical laboratories, diagnostic reagents for scientific or research use, assay reagents, other than those for medical use, assay reagents for industrial use, immunoassay reagents, other than those for medical use, laboratory reagents for scientific use, reagents for microbiological analysis not for medical or veterinary use, reagents for chemical analysis, reagents for research, reagents for medical research, reagents for use in immunoserology, reagents for use in scientific apparatus for chemical or biological analysis, reagents for use with analyzers, other than for medical or veterinary use, diagnostic reagents for medical or veterinary use, immunoassay reagents for medical or veterinary use, medical reagents for clinical use, reagents for clinical analysis for medical or veterinary use, reagents for microbiological analysis for medical or veterinary use, reagents for use in analyzers for medical or veterinary use, reagents for in-vitro use in laboratories for medical or veterinary use, chemical reagents for testing for medical or veterinary use, computer applications and computer programs intended for laboratory information systems, data management for specific clinical applications, comprehensive solutions for communication, clinical diagnosis and patient-focused systems, such as management of therapies, chronic disorders and telemedicine, medico-surgical products for use in the hospital sector, scientific, analytical and laboratory instruments; procurement, namely, purchasing goods for others in the nature of in-vitro diagnosis and analysis products, apparatus and instruments, diagnostic kits comprising receivers for samples and reagents for testing selected bacteria, equipment for biomolecular tagging consisting of reagents for use in scientific research, mixtures of chemical reagents in kit form, other than those for medical or veterinary use, mixtures of chemical reagents, not for medical or veterinary use, testing reagents for scientific use, monoclonal antibody reagents for medical use, diagnostic reagents, other than for use in medical laboratories, diagnostic reagents for scientific or research use, assay reagents, other than those for medical use, assay reagents for industrial use, immunoassay reagents, other than those for medical use, laboratory reagents for scientific use, reagents for microbiological analysis not for medical or veterinary use, reagents for chemical analysis, reagents for research, reagents for medical research, reagents for use in immunoserology, reagents for use in scientific apparatus for chemical or biological analysis, reagents for use with analyzers, other than for medical or veterinary use, diagnostic reagents for medical or veterinary use, immunoassay reagents for medical or veterinary use, medical reagents for clinical use, reagents for clinical analysis for medical or veterinary use, reagents for microbiological analysis for medical or veterinary use, reagents for use in analyzers for medical or veterinary use, reagents for in-vitro use in laboratories for medical or veterinary use, chemical reagents for testing for medical or veterinary use, computer applications and computer programs intended for laboratory information systems, data management for specific clinical applications, comprehensive solutions for communication, clinical diagnosis and patient-focused systems, such as management of therapies, chronic disorders and telemedicine, medico-surgical products for use in the hospital sector, scientific, analytical and laboratory instruments; import-export agencies in the field of in-vitro diagnosis and analysis products, apparatus and instruments, diagnostic kits comprising receivers for samples and reagents for testing selected bacteria, equipment for biomolecular tagging consisting of reagents for use in scientific research, mixtures of chemical reagents in kit form, other than those for medical or veterinary use, mixtures of chemical reagents, not for medical or veterinary use, testing reagents for scientific use, monoclonal antibody reagents for medical use, diagnostic reagents, other than for use in medical laboratories, diagnostic reagents for scientific or research use, assay reagents, other than those for medical use, assay reagents for industrial use, immunoassay reagents, other than those for medical use, laboratory reagents for scientific use, reagents for microbiological analysis not for medical or veterinary use, reagents for chemical analysis, reagents for research, reagents for medical research, reagents for use in immunoserology, reagents for use in scientific apparatus for chemical or biological analysis, reagents for use with analyzers, other than for medical or veterinary use, diagnostic reagents for medical or veterinary use, immunoassay reagents for medical or veterinary use, medical reagents for clinical use, reagents for clinical analysis for medical or veterinary use, reagents for microbiological analysis for medical or veterinary use, reagents for use in analyzers for medical or veterinary use, reagents for in-vitro use in laboratories for medical or veterinary use, chemical reagents for testing for medical or veterinary use, computer applications and computer programs intended for laboratory information systems, data management for specific clinical applications, comprehensive solutions for communication, clinical diagnosis and patient-focused systems, such as management of therapies, chronic disorders and telemedicine, medico-surgical products for use in the hospital sector, scientific, analytical and laboratory instruments | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by WERFEN S.A.
- Other trademarks owned by WERFENLIFE S.A.
- Other trademarks owned by WERFENLIFE S.A.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Similar marks named WERFEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 3, 2026 | C71T | CANCELLED SECTION 71 | — |
| Nov 13, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 18, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 18, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 18, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 18, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 18, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 17, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 24, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 23, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 9, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 17, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 30, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 30, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 17, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 17, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 5, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 1, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 1, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 18, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 18, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 11, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 29, 2019 | ALIE | ASSIGNED TO LIE | — |
| Aug 23, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 23, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 23, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 23, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 23, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 2, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 2, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 23, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 7, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 7, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 28, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 27, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 23, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 19, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 19, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 14, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |